Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release May 11 2022

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-11-2022-13

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 11-May-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 mL Unit-dose Vial

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases